Article
Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease.
Transfusion - 1 May 2025
Malta Barbara, Cintho Ozahata Mina, Gomes Moura Isabel Cristina, Amorim Luiz, Ferraz Alessandra, Belisário André Rolim, Miranda Carolina, Kelly Shannon, Custer Brian, Sabino Ester C, Dinardo Carla L
Abstract excerpt
BACKGROUND: Hyperhemolysis syndrome (HHS) is a severe transfusion-related complication with a complex immune pathophysiology, primarily affecting individuals with sickle cell disease (SCD). Limited research has investigated the clinical and molecular risk factors for HHS, which could help identify at-risk patients. This study aimed to assess clinical factors associated with HHS and identify genetic variations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
